等待开盘 10-23 09:30:00 美东时间
-1.202
-1.32%
Ethan Allen outlines five key reasons to vote for its director nominees, emphasizing its debt-free platform, sustainable growth strategy, and ongoing CEO transition. The company criticizes DGB's proposed plan, stating it fails to demonstrate superiority or justify board changes. Ethan Allen highlights its vertically integrated business, strong financials, and current growth initiatives, while questioning DGB's lack of validated financial assumpti...
10-19 14:34
Alaunos Therapeutics completes acquisition of Velaris Therapeutics and raises $350 million via private placement to advance PAH therapies. Velaris' pipeline includes ActRII-Fc ligand traps and anti-PDGF-B antibody targeting pulmonary vascular remodeling. The funding supports clinical proof-of-concept data for VLR199 by 2028 and expansion into secondary pulmonary hypertension.
10-13 14:31
TipRanks平台的人工智能分析师将三只ETF评为“跑赢大盘(买入)”评级,三只产品分别为维特思Silvant增长机遇ETF(代码VGRO)、一号引擎Tra...
07-01 03:27